GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EGF Theramed Health Corp (OTCPK:EVAHF) » Definitions » Debt-to-EBITDA

EGF Theramed Health (EGF Theramed Health) Debt-to-EBITDA : -13.26 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is EGF Theramed Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

EGF Theramed Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.06 Mil. EGF Theramed Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. EGF Theramed Health's annualized EBITDA for the quarter that ended in Dec. 2023 was $-0.08 Mil. EGF Theramed Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -13.26.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for EGF Theramed Health's Debt-to-EBITDA or its related term are showing as below:

EVAHF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -18.15   Med: -1.28   Max: 2.41
Current: -4.98

During the past 12 years, the highest Debt-to-EBITDA Ratio of EGF Theramed Health was 2.41. The lowest was -18.15. And the median was -1.28.

EVAHF's Debt-to-EBITDA is ranked worse than
100% of 421 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs EVAHF: -4.98

EGF Theramed Health Debt-to-EBITDA Historical Data

The historical data trend for EGF Theramed Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGF Theramed Health Debt-to-EBITDA Chart

EGF Theramed Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 -0.07 -1.65 -0.90 -2.21

EGF Theramed Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.67 -4.49 -2.59 -6.10 -13.26

Competitive Comparison of EGF Theramed Health's Debt-to-EBITDA

For the Health Information Services subindustry, EGF Theramed Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EGF Theramed Health's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EGF Theramed Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where EGF Theramed Health's Debt-to-EBITDA falls into.



EGF Theramed Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

EGF Theramed Health's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.314 + 0.692) / -0.456
=-2.21

EGF Theramed Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.061 + 0) / -0.08
=-13.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


EGF Theramed Health  (OTCPK:EVAHF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


EGF Theramed Health Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of EGF Theramed Health's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


EGF Theramed Health (EGF Theramed Health) Business Description

Traded in Other Exchanges
Address
609 Granville Street, Suite 1600, P.O. Box 10068,, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. The company explores many other medical areas including weight loss, skincare and heart disease.